CL2007003855A1 - COMPOSITION THAT INCLUDES A SUBSTRATE VEHICLE AND A DEPOSIT ON SUCH SUBSTRATE VEHICLE, WHERE SUCH DEPOSIT INCLUDES PARTICLES OF A PREGNAN DERIVATIVE COMPOUND; CAPSULE AND TABLET THAT UNDERSTAND IT; AND USE IN THE TREATMENT OF DISEASES T - Google Patents

COMPOSITION THAT INCLUDES A SUBSTRATE VEHICLE AND A DEPOSIT ON SUCH SUBSTRATE VEHICLE, WHERE SUCH DEPOSIT INCLUDES PARTICLES OF A PREGNAN DERIVATIVE COMPOUND; CAPSULE AND TABLET THAT UNDERSTAND IT; AND USE IN THE TREATMENT OF DISEASES T

Info

Publication number: CL2007003855A1
Authority: CL; Chile
Prior art keywords: deposit; substrate vehicle; capsule; tablet; diseases
Prior art date: 2006-12-28

Application number

CL200703855A

Other languages

Spanish (es)

Inventor

Joseph Podolski

Original Assignee

Repros Therapeutics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-12-28

Filing date

2007-12-28

Publication date

2008-03-14

2007-12-28 Application filed by Repros Therapeutics Inc filed Critical Repros Therapeutics Inc

2008-03-14 Publication of CL2007003855A1 publication Critical patent/CL2007003855A1/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
- A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Epidemiology (AREA)
Gynecology & Obstetrics (AREA)
Pregnancy & Childbirth (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)

CL200703855A 2006-12-28 2007-12-28 COMPOSITION THAT INCLUDES A SUBSTRATE VEHICLE AND A DEPOSIT ON SUCH SUBSTRATE VEHICLE, WHERE SUCH DEPOSIT INCLUDES PARTICLES OF A PREGNAN DERIVATIVE COMPOUND; CAPSULE AND TABLET THAT UNDERSTAND IT; AND USE IN THE TREATMENT OF DISEASES T CL2007003855A1 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US88242306P	2006-12-28	2006-12-28
US88537207P	2007-01-17	2007-01-17

Publications (1)

Publication Number	Publication Date
CL2007003855A1 true CL2007003855A1 (en)	2008-03-14

Family

ID=39589194

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CL200703855A CL2007003855A1 (en)	2006-12-28	2007-12-28	COMPOSITION THAT INCLUDES A SUBSTRATE VEHICLE AND A DEPOSIT ON SUCH SUBSTRATE VEHICLE, WHERE SUCH DEPOSIT INCLUDES PARTICLES OF A PREGNAN DERIVATIVE COMPOUND; CAPSULE AND TABLET THAT UNDERSTAND IT; AND USE IN THE TREATMENT OF DISEASES T

Country Status (14)

Country	Link
EP (1)	EP2094275A2 (en)
JP (1)	JP2010514793A (en)
KR (1)	KR20090086470A (en)
AR (1)	AR064697A1 (en)
AU (1)	AU2007339820A1 (en)
CA (1)	CA2672888A1 (en)
CL (1)	CL2007003855A1 (en)
CO (1)	CO6190605A2 (en)
EA (1)	EA200970646A1 (en)
EC (1)	ECSP099536A (en)
MX (1)	MX2009006912A (en)
NO (1)	NO20092271L (en)
TW (1)	TW200831110A (en)
WO (1)	WO2008083192A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US8299050B2 (en) *	2008-01-29	2012-10-30	Laboratoire Hra-Pharma	Method for treating uterine fibroids
US8512745B2 (en)	2008-12-08	2013-08-20	Laboratoire Hra Pharma	Ulipristal acetate tablets
ES2602134T3 (en)	2009-04-14	2017-02-17	Laboratoire Hra Pharma	Contraceptive procedure on demand
EP2471537A1 (en) *	2010-12-30	2012-07-04	PregLem S.A.	Treatment of pain associated with dislocation of basal endometrium
EP2545922A1 (en)	2011-07-12	2013-01-16	PregLem S.A.	Treatment of excessive menstrual bleeding associated with uterine fibroids
IN2014CN03214A (en) *	2011-10-21	2015-07-03	Seachaid Pharmaceuticals Inc
FR2997628B1 (en) *	2012-11-08	2015-01-16	Hra Pharma Lab	CO-MICRONIZATION PRODUCT COMPRISING A SELECTIVE MODULATOR OF PROGESTERONE RECEPTORS
FR2997627B1 (en) *	2012-11-08	2015-01-16	Hra Pharma Lab	CO-MICRONIZATION PRODUCT COMPRISING ULIPRISTAL ACETATE
FR2999081B1 (en) *	2012-12-06	2015-02-27	Hra Pharma Lab	SOLID DISPERSION OF A SELECTIVE PROGESTERONE RECEPTOR MODULATOR
EA030831B1 (en)	2013-04-10	2018-10-31	Преглем Са	Method for treating uterine fibroids
WO2018106914A1 (en) *	2016-12-09	2018-06-14	Repros Therapeutics Inc.	Oral pharmaceutical compositions comprising an unmicronized selective progesterone receptor as active agent
WO2017216637A2 (en)	2017-08-04	2017-12-21	Alvogen Malta Operations (Row) Ltd	Tablet form including ulipristal acetate and the methods for its preparation
US11878025B2 (en)	2021-09-06	2024-01-23	Slayback Pharma Llc	Pharmaceutical compositions of mifepristone

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP4260886B2 (en) *	1996-05-01	2009-04-30	アメリカ合衆国	21-Substituted progesterone derivatives as novel anti-progesterone
US6248363B1 (en) *	1999-11-23	2001-06-19	Lipocine, Inc.	Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
FR2821555B1 (en) *	2001-03-01	2003-05-16	Besins Int Lab	PROGESTIVE CO-MICRONIZED WITH A SURFACTANT, PHARMACEUTICAL COMPOSITION COMPRISING SAME, METHODS OF MAKING SAME AND USES THEREOF
US20050220825A1 (en) *	2004-03-10	2005-10-06	Adrian Funke	Molecular dispersions of drospirenone
KR20080055956A (en) *	2005-09-29	2008-06-19	레프로스 쎄라피우틱스 아이엔씨.	Formulations with improved bioavailability, comprising a steroid derivative and a polyglycolysed glyceride

2007
- 2007-12-27 JP JP2009544257A patent/JP2010514793A/en active Pending
- 2007-12-27 TW TW096150635A patent/TW200831110A/en unknown
- 2007-12-27 AU AU2007339820A patent/AU2007339820A1/en not_active Abandoned
- 2007-12-27 KR KR1020097014099A patent/KR20090086470A/en not_active Application Discontinuation
- 2007-12-27 EP EP07869940A patent/EP2094275A2/en not_active Withdrawn
- 2007-12-27 MX MX2009006912A patent/MX2009006912A/en not_active Application Discontinuation
- 2007-12-27 CA CA002672888A patent/CA2672888A1/en not_active Abandoned
- 2007-12-27 WO PCT/US2007/088891 patent/WO2008083192A2/en active Application Filing
- 2007-12-27 EA EA200970646A patent/EA200970646A1/en unknown
- 2007-12-28 CL CL200703855A patent/CL2007003855A1/en unknown
- 2007-12-28 AR ARP070105971A patent/AR064697A1/en unknown
2009
- 2009-06-12 NO NO20092271A patent/NO20092271L/en not_active Application Discontinuation
- 2009-06-25 CO CO09066124A patent/CO6190605A2/en not_active Application Discontinuation
- 2009-07-23 EC EC2009009536A patent/ECSP099536A/en unknown

Also Published As

Publication number	Publication date
EA200970646A1 (en)	2009-12-30
CA2672888A1 (en)	2008-07-10
WO2008083192A8 (en)	2009-07-09
MX2009006912A (en)	2009-08-12
ECSP099536A (en)	2009-08-28
WO2008083192A2 (en)	2008-07-10
WO2008083192A3 (en)	2008-11-27
TW200831110A (en)	2008-08-01
AR064697A1 (en)	2009-04-22
AU2007339820A1 (en)	2008-07-10
KR20090086470A (en)	2009-08-12
CO6190605A2 (en)	2010-08-19
EP2094275A2 (en)	2009-09-02
NO20092271L (en)	2009-08-06
JP2010514793A (en)	2010-05-06

Similar Documents

Publication	Publication Date	Title
CL2007003855A1 (en)	2008-03-14	COMPOSITION THAT INCLUDES A SUBSTRATE VEHICLE AND A DEPOSIT ON SUCH SUBSTRATE VEHICLE, WHERE SUCH DEPOSIT INCLUDES PARTICLES OF A PREGNAN DERIVATIVE COMPOUND; CAPSULE AND TABLET THAT UNDERSTAND IT; AND USE IN THE TREATMENT OF DISEASES T
CL2007003138A1 (en)	2008-06-27	COMPOUNDS DERIVED FROM ANILINOPIPERAZINA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CANCER.
CL2007002916A1 (en)	2008-04-18	COMPOUNDS DERIVED FROM PIRAZOLILTIENOPIRIDINAS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE INHIBITION OF ESCARAS.
CL2007003244A1 (en)	2008-04-04	COMPOUNDS DERIVED FROM PIRIMIDO [5,4-D] [2] BENZAZEPINA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CANCER.
CL2007003797A1 (en)	2008-07-18	COMPOUNDS DERIVED FROM PIRROLO PIRIDINA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; AND ITS USE FOR THE TREATMENT OF THE DISEASE OF ALZHEIMER, PARKINSON, CANCER, AMONG OTHER ILLNESSES.
CL2007002594A1 (en)	2008-06-06	COMPOUNDS DERIVED FROM PIRIDIN-3-IL, IMMUNOMODULATING AGENTS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE TREATMENT OF DISEASES ASSOCIATED WITH AN ACTIVATED IMMUNOLOGICAL SYSTEM. .
CL2007002234A1 (en)	2008-06-13	COMPOUNDS DERIVED FROM NITROGEN HETEROCICLES; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF PROLIFERATIVE DISEASES.
ATE532788T1 (en)	2011-11-15	PHARMACEUTICAL COMPOUNDS
CL2007003226A1 (en)	2008-02-08	COMPOUNDS DERIVED FROM PIRIDINONA; PHARMACEUTICAL COMPOSITION; AND USE TO TREAT CANCER.
CL2007001992A1 (en)	2008-07-18	COMPOUNDS DERIVED FROM PYRIMIDILCICLOPENTANOS; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN THE TREATMENT OF AN INFLAMMATORY, HYPERPROLIFERANT, CARDIOVASCULAR, NEURODEGE DISEASE
CL2007002316A1 (en)	2008-02-01	COMPOUNDS DERIVED FROM PYRIMIDINE, PI3K INHIBITORS; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND IN PROLIFERATIVE DISEASES AS CANCER.
CL2007002261A1 (en)	2008-05-02	COMPOUNDS DERIVED FROM IMIDAZO [1,2-B] PIRIDAZINA, QUINASA INHIBITORS; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OR PREVENTION OF CANCER.
IL196033A0 (en)	2009-09-01	Pyrrolotriazine derivatives and pharmaceutical compositions containing the same
CL2007003202A1 (en)	2008-03-07	COMPOUNDS DERIVED FROM ESPIROINDOLINONA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF CELL PROLIFERATION DISORDERS.
ATE489079T1 (en)	2010-12-15	MULTI-LAYER TABLET WITH TRIPLE RELEASE COMBINATION
CL2007001902A1 (en)	2008-04-04	COMPOUNDS DERIVED FROM SUBSTITUTED PIRIDINE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF A DISORDER OF AGGREGATION OF PLATES.
CL2007003523A1 (en)	2008-08-22	COMPOUNDS DERIVED FROM HETEROCICLES REPLACED WITH MORFOLINA, INHIBITORS OF THE ACTIVITY OF PI3 QUINASA; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUNDS; PHARMACEUTICAL KIT; AND ITS USE IN THE CANCER PROFILACTIC OR THERAPEUTIC TREATMENT
BRPI0814593A2 (en)	2015-01-20	COMPOUND, PHARMACEUTICAL COMPOSITION CONTAINING AND USE OF THE COMPOUND.
CL2007001630A1 (en)	2008-02-08	COMPOUNDS DERIVED FROM PIRROLIDINAMIDE; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF HEPATITIS C.
CL2007002920A1 (en)	2008-06-06	COMPOUNDS DERIVED FROM 2-AMINOCARBONYLPIRIDINE; PHARMACEUTICAL COMPOSITION; AND USE FOR THE TREATMENT OF OCLUSIVE VASCULAR DISORDERS.
CL2007002494A1 (en)	2008-04-04	PHARMACEUTICAL COMPOSITION THAT INCLUDES A PIRIMIDINE TRISUSTITUIDA IN COMBINATION WITH A COMPOUND WITH INHIBITORY PROPERTIES OF PDE5; AND USE IN THE TREATMENT OF A DISEASE THAT INVOLVES VASOCONSTRICTION.
DE602007005372D1 (en)	2010-04-29	TWO-TABLE TABLET FOR PREVENTING CARDIOVASCULAR EVENTS
CL2007002479A1 (en)	2008-02-29	COMPOUNDS DERIVED FROM PIRAZOL; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF THROMBOEMBOLIC DISORDERS.
CL2007003038A1 (en)	2008-06-06	COMPOUNDS DERIVED FROM 2-PHENYL-6-AMINOCARBONIL-PYRIMIDINE; PHARMACEUTICAL COMPOSITION; AND USE IN THE TREATMENT OF OCLUSIVE VASCULAR DISORDERS.
DK200900115U1 (en)	2009-10-23	Novel pharmaceutical modified release dosage form cyclooxygenase enzyme inhibitor